Viewing Study NCT00227760


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2025-12-26 @ 12:36 AM
Study NCT ID: NCT00227760
Status: COMPLETED
Last Update Posted: 2016-02-29
First Post: 2005-09-26
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Cediranib Maleate in Treating Patients With Recurrent or Metastatic Kidney Cancer That Cannot Be Removed By Surgery
Sponsor: National Cancer Institute (NCI)
Organization: